An in-silico evaluation of COVID-19 main protease with clinically approved drugs

A novel strain of coronavirus, namely, SARS-CoV-2 identified in Wuhan city of China in December 2019, continues to spread at a rapid rate worldwide. There are no specific therapies available and investigations regarding the treatment of this disease are still lacking. In order to identify a novel po...

Descripción completa

Detalles Bibliográficos
Autores principales: Tachoua, Wafa, Kabrine, Mohamed, Mushtaq, Mamona, Ul-Haq, Zaheer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Topical Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503128/
https://www.ncbi.nlm.nih.gov/pubmed/33007575
http://dx.doi.org/10.1016/j.jmgm.2020.107758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503128/
https://www.ncbi.nlm.nih.gov/pubmed/33007575
http://dx.doi.org/10.1016/j.jmgm.2020.107758

Ejemplares similares